{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:35:43Z","timestamp":1791232543547,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,4,4]],"date-time":"2009-04-04T00:00:00Z","timestamp":1238803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s11910-009-0034-5","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T01:59:43Z","timestamp":1238723983000},"page":"231-240","source":"Crossref","is-referenced-by-count":75,"title":["Advances in meningioma therapy"],"prefix":"10.1007","volume":"9","author":[{"given":"Andrew D.","family":"Norden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Drappatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Y.","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,4]]},"reference":[{"key":"34_CR1","unstructured":"Central Brain Tumor Registry of the United States: Statistical Report: Primary Brain Tumors in the United States, 2000\u20132004. Available at http:\/\/www.cbtrus.org\/reports\/\/2007-2008\/2007report.pdf . Accessed February 11, 2009."},{"key":"34_CR2","unstructured":"Meningeal tumors. In WHO Classification of Tumors. Tumors of the Nervous System. Edited by Kleihues P, Cavenee WK. Lyon, France: IARC; 2000:175\u2013196."},{"key":"34_CR3","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/jnnp.2007.121582","volume":"79","author":"S.Y. Yang","year":"2008","unstructured":"Yang SY, Park CK, Park SH, et al.: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 2008, 79:574\u2013580.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","volume":"63","author":"K. Lamszus","year":"2004","unstructured":"Lamszus K: Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004, 63:275\u2013286.","journal-title":"J Neuropathol Exp Neurol"},{"key":"34_CR5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1227\/01.NEU.0000290895.92695.22","volume":"61","author":"N. Krayenbuhl","year":"2007","unstructured":"Krayenbuhl N, Pravdenkova S, Al-Mefty O: De novo versus transformed atypical and anaplastic meningiomas: comparisons of clinical course, cytogenetics, cytokinetics, and outcome. Neurosurgery 2007, 61:495\u2013503; discussion 503\u2013494.","journal-title":"Neurosurgery"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D. Pasquier","year":"2008","unstructured":"Pasquier D, Bijmolt S, Veninga T, et al.: Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2008, 71:1388\u20131393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"34_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"M.H. Ruttledge","year":"1994","unstructured":"Ruttledge MH, Sarrazin J, Rangaratnam S, et al.: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994, 6:180\u2013184.","journal-title":"Nat Genet"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1227\/01.NEU.0000255421.78431.AE","volume":"60","author":"M. Simon","year":"2007","unstructured":"Simon M, Bostrom JP, Hartmann C: Molecular genetics of meningiomas: from basic research to potential clinical applications. Neurosurgery 2007, 60:787\u2013798; discussion 787\u2013798.","journal-title":"Neurosurgery"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2164-8-16","volume":"8","author":"C.M. Hansson","year":"2007","unstructured":"Hansson CM, Buckley PG, Grigelioniene G, et al.: Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genomics 2007, 8:16.","journal-title":"BMC Genomics"},{"key":"34_CR10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1593\/neo.08642","volume":"10","author":"K. Striedinger","year":"2008","unstructured":"Striedinger K, VandenBerg SR, Baia GS, et al.: The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia 2008, 10:1204\u20131212.","journal-title":"Neoplasia"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awm249","volume":"131","author":"C.O. Hanemann","year":"2008","unstructured":"Hanemann CO: Magic but treatable? Tumours due to loss of merlin. Brain 2008, 131:606\u2013615.","journal-title":"Brain"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2008.01.020","volume":"183","author":"K. Wozniak","year":"2008","unstructured":"Wozniak K, Piaskowski S, Gresner SM, et al.: BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genet Cytogenet 2008, 183:14\u201320.","journal-title":"Cancer Genet Cytogenet"},{"key":"34_CR13","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jnen\/59.10.872","volume":"59","author":"A. Perry","year":"2000","unstructured":"Perry A, Cai DX, Scheithauer BW, et al.: Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 2000, 59:872\u2013879.","journal-title":"J Neuropathol Exp Neurol"},{"key":"34_CR14","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1158\/0008-5472.CAN-05-1628","volume":"66","author":"M.A. Gerber","year":"2006","unstructured":"Gerber MA, Bahr SM, Gutmann DH: Protein 4.1B\/differentially expressed in adenocarcinoma of the lung-1 functions as a growth suppressor in meningioma cells by activating Rac1-dependent c-Jun-NH(2)-kinase signaling. Cancer Res 2006, 66:5295\u20135303.","journal-title":"Cancer Res"},{"key":"34_CR15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1227\/01.NEU.0000311062.72626.D6","volume":"62","author":"R. Ketter","year":"2008","unstructured":"Ketter R, Rahnenfuhrer J, Henn W, et al.: Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas. Neurosurgery 2008, 62:61\u201369; discussion 69\u201370.","journal-title":"Neurosurgery"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/ijc.22855","volume":"121","author":"R. Ketter","year":"2007","unstructured":"Ketter R, Urbschat S, Henn W, et al.: Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas. Int J Cancer 2007, 121:1473\u20131480.","journal-title":"Int J Cancer"},{"key":"34_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1227\/01.neu.0000303201.62123.5c","volume":"61","author":"W.K. Pfisterer","year":"2007","unstructured":"Pfisterer WK, Hendricks WP, Scheck AC, et al.: Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas? Neurosurgery 2007, 61:1048\u20131059; discussion 1060\u20131041.","journal-title":"Neurosurgery"},{"key":"34_CR18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1215\/15228517-2007-026","volume":"9","author":"A. Maillo","year":"2007","unstructured":"Maillo A, Orfao A, Espinosa AB, et al.: Early recurrences in histologically benign\/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Neuro Oncol 2007, 9:438\u2013446.","journal-title":"Neuro Oncol"},{"key":"34_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1158\/0008-5472.CAN-07-1796","volume":"68","author":"E.B. Claus","year":"2008","unstructured":"Claus EB, Park PJ, Carroll R, et al.: Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 2008, 68:314\u2013322.","journal-title":"Cancer Res"},{"key":"34_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1593\/neo.08356","volume":"10","author":"G.S. Baia","year":"2008","unstructured":"Baia GS, Stifani S, Kimura ET, et al.: Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 2008, 10:604\u2013612.","journal-title":"Neoplasia"},{"key":"34_CR21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.23942","volume":"124","author":"A. Keller","year":"2009","unstructured":"Keller A, Ludwig N, Backes C, et al.: Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer 2009, 124:346\u2013351.","journal-title":"Int J Cancer"},{"key":"34_CR22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2174\/092986708783955527","volume":"15","author":"V. Martinez-Glez","year":"2008","unstructured":"Martinez-Glez V, Franco-Hernandez C, Rey JA: Microarray gene expression profiling in meningiomas and schwannomas. Curr Med Chem 2008, 15:826\u2013833.","journal-title":"Curr Med Chem"},{"key":"34_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-008-9569-6","volume":"88","author":"M. Aarhus","year":"2008","unstructured":"Aarhus M, Bruland O, Bredholt G, et al.: Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. J Neurooncol 2008, 88:251\u2013259.","journal-title":"J Neurooncol"},{"key":"34_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cancergencyto.2008.03.015","volume":"184","author":"W. Krupp","year":"2008","unstructured":"Krupp W, Holland H, Koschny R, et al.: Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics. Cancer Genet Cytogenet 2008, 184:87\u201393.","journal-title":"Cancer Genet Cytogenet"},{"key":"34_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jnci\/djn004","volume":"100","author":"L. Bethke","year":"2008","unstructured":"Bethke L, Murray A, Webb E, et al.: Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 2008, 100:270\u2013276.","journal-title":"J Natl Cancer Inst"},{"key":"34_CR26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/1055-9965.EPI-07-0314","volume":"16","author":"P. Rajaraman","year":"2007","unstructured":"Rajaraman P, Wang SS, Rothman N, et al.: Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007, 16:1655\u20131661.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"34_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","volume":"67","author":"C. Marosi","year":"2008","unstructured":"Marosi C, Hassler M, Roessler K, et al.: Meningioma. Crit Rev Oncol Hematol 2008, 67:153\u2013171.","journal-title":"Crit Rev Oncol Hematol"},{"key":"34_CR28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D. Simpson","year":"1957","unstructured":"Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957, 20:22\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR29","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1227\/01.neu.0000333778.66316.38","volume":"62","author":"P.M. Black","year":"2008","unstructured":"Black PM, Morokoff AP, Zauberman J: Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery 2008, 62:1115\u20131121; discussion 1121\u20131113.","journal-title":"Neurosurgery"},{"key":"34_CR30","doi-asserted-by":"crossref","unstructured":"Butte PV, Pikul BK, Hever A, et al.: Diagnosis of meningioma by time-resolved fluorescence spectroscopy. J Biomed Opt 2005, 10:064026.","DOI":"10.1117\/1.2141624"},{"key":"34_CR31","first-page":"107","volume":"57","author":"E. Gay","year":"2005","unstructured":"Gay E, Vuillez JP, Palombi O, et al.: Intraoperative and postoperative gamma detection of somatostatin receptors in bone-invasive en plaque meningiomas. Neurosurgery 2005, 57:107\u2013113; discussion 107\u2013113.","journal-title":"Neurosurgery"},{"key":"34_CR32","first-page":"102","volume":"62","author":"Y. Morofuji","year":"2008","unstructured":"Morofuji Y, Matsuo T, Hayashi Y, et al.: Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: technical case report. Neurosurgery 2008, 62:102\u2013103; discussion 103\u2013104.","journal-title":"Neurosurgery"},{"key":"34_CR33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","volume":"26","author":"J. Jaaskelainen","year":"1986","unstructured":"Jaaskelainen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986, 26:461\u2013469.","journal-title":"Surg Neurol"},{"key":"34_CR34","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC\/2008\/24\/5\/E2","volume":"24","author":"W.D. Johnson","year":"2008","unstructured":"Johnson WD, Loredo LN, Slater JD: Surgery and radiotherapy: complementary tools in the management of benign intracranial tumors. Neurosurg Focus 2008, 24:E2.","journal-title":"Neurosurg Focus"},{"key":"34_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2004-836225","volume":"66","author":"M. Nakamura","year":"2005","unstructured":"Nakamura M, Roser F, Michel J, et al.: Volumetric analysis of the growth rate of incompletely resected intracranial meningiomas. Zentralbl Neurochir 2005, 66:17\u201323.","journal-title":"Zentralbl Neurochir"},{"key":"34_CR36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-008-0801-2","volume":"255","author":"L.A. Zeidman","year":"2008","unstructured":"Zeidman LA, Ankenbrandt WJ, Du H, et al.: Growth rate of non-operated meningiomas. J Neurol 2008, 255:891\u2013895.","journal-title":"J Neurol"},{"key":"34_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0360-3016(99)00349-1","volume":"46","author":"L.K. Goyal","year":"2000","unstructured":"Goyal LK, Suh JH, Mohan DS, et al.: Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys 2000, 46:57\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"34_CR38","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/FOC-07\/10\/E4","volume":"23","author":"L. Rogers","year":"2007","unstructured":"Rogers L, Mehta M: Role of radiation therapy in treating intracranial meningiomas. Neurosurg Focus 2007, 23:E4.","journal-title":"Neurosurg Focus"},{"key":"34_CR39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ijrobp.2006.12.073","volume":"68","author":"S. Milker-Zabel","year":"2007","unstructured":"Milker-Zabel S, Zabel-du Bois A, Huber P, et al.: Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 2007, 68:858\u2013863.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"34_CR40","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2001.19.15.3547","volume":"19","author":"J. Debus","year":"2001","unstructured":"Debus J, Wuendrich M, Pirzkall A, et al.: High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 2001, 19:3547\u20133553.","journal-title":"J Clin Oncol"},{"key":"34_CR41","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/FOC-07\/10\/E5","volume":"23","author":"A.E. Elia","year":"2007","unstructured":"Elia AE, Shih HA, Loeffler JS: Stereotactic radiation treatment for benign meningiomas. Neurosurg Focus 2007, 23:E5.","journal-title":"Neurosurg Focus"},{"key":"34_CR42","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/foc.2003.14.5.6","volume":"14","author":"R.C. Torres","year":"2003","unstructured":"Torres RC, Frighetto L, De Salles AA, et al.: Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurg Focus 2003, 14:E5.","journal-title":"Neurosurg Focus"},{"key":"34_CR43","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3171\/jns.1996.84.5.0733","volume":"84","author":"M.C. Chamberlain","year":"1996","unstructured":"Chamberlain MC: Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 1996, 84:733\u2013736.","journal-title":"J Neurosurg"},{"key":"34_CR44","first-page":"2269","volume":"7","author":"C. Muhr","year":"2001","unstructured":"Muhr C, Gudjonsson O, Lilja A, et al.: Meningioma treated with interferon-alpha, evaluated with [(11)C]-l-methionine positron emission tomography. Clin Cancer Res 2001, 7:2269\u20132276.","journal-title":"Clin Cancer Res"},{"key":"34_CR45","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","volume":"62","author":"M.C. Chamberlain","year":"2004","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S: Temozolomide for treatment-resistant recurrent meningioma. Neurology 2004, 62:1210\u20131212.","journal-title":"Neurology"},{"key":"34_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cancergencyto.2008.07.006","volume":"187","author":"P. Robles de","year":"2008","unstructured":"de Robles P, McIntyre J, Kalra S, et al.: Methylation status of MGMT gene promoter in meningiomas. Cancer Genet Cytogenet 2008, 187:25\u201327.","journal-title":"Cancer Genet Cytogenet"},{"key":"34_CR47","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11060-005-9093-x","volume":"78","author":"M.C. Chamberlain","year":"2006","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S: Salvage chemotherapy with CPT-11 for recurrent meningioma. J Neurooncol 2006, 78:271\u2013276.","journal-title":"J Neurooncol"},{"key":"34_CR48","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/FOC-07\/10\/E11","volume":"23","author":"H.B. Newton","year":"2007","unstructured":"Newton HB: Hydroxyurea chemotherapy in the treatment of meningiomas. Neurosurg Focus 2007, 23:E11.","journal-title":"Neurosurg Focus"},{"key":"34_CR49","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3171\/jns.2007.106.6.1034","volume":"106","author":"J.S. Smith","year":"2007","unstructured":"Smith JS, Lal A, Harmon-Smith M, et al.: Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg 2007, 106:1034\u20131040.","journal-title":"J Neurosurg"},{"key":"34_CR50","first-page":"454","volume":"8","author":"P.Y. Wen","year":"2006","unstructured":"Wen PY, Yung WKA, Lamborn K, et al.: Phase II study of imatinib mesylate (STI571) for patients with recurrent meningiomas (NABTC 01-08) [abstract]. Neuro Oncol 2006, 8:454.","journal-title":"Neuro Oncol"},{"key":"34_CR51","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/FOC-07\/10\/E9","volume":"23","author":"V. Gupta","year":"2007","unstructured":"Gupta V, Samuleson CG, Su S, Chen TC: Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Neurosurg Focus 2007, 23:E9.","journal-title":"Neurosurg Focus"},{"key":"34_CR52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-004-5233-y","volume":"73","author":"E.A. Lusis","year":"2005","unstructured":"Lusis EA, Chicoine MR, Perry A: High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 2005, 73:219\u2013223.","journal-title":"J Neurooncol"},{"key":"34_CR53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/02724570152057634","volume":"20","author":"T. Crombet","year":"2001","unstructured":"Crombet T, Torres O, Rodriguez V, et al.: Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study. Hybridoma 2001, 20:131\u2013136.","journal-title":"Hybridoma"},{"key":"34_CR54","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/01.jnen.0000189834.63951.81","volume":"64","author":"M. Johnson","year":"2005","unstructured":"Johnson M, Toms S: Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy? J Neuropathol Exp Neurol 2005, 64:1029\u20131036.","journal-title":"J Neuropathol Exp Neurol"},{"key":"34_CR55","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"R.S. Kerbel","year":"2008","unstructured":"Kerbel RS: Tumor angiogenesis. N Engl J Med 2008, 358:2039\u20132049.","journal-title":"N Engl J Med"},{"key":"34_CR56","first-page":"938","volume":"46","author":"K. Lamszus","year":"2000","unstructured":"Lamszus K, Lengler U, Schmidt NO, et al.: Vascular endothelial growth factor, hepatocyte growth factor\/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000, 46:938\u2013947; discussion 947\u2013938.","journal-title":"Neurosurgery"},{"key":"34_CR57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11060-006-9294-y","volume":"83","author":"P. Kan","year":"2007","unstructured":"Kan P, Liu JK, Wendland MM, et al.: Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol 2007, 83:33\u201338.","journal-title":"J Neurooncol"},{"key":"34_CR58","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00006123-199705000-00027","volume":"40","author":"J. Provias","year":"1997","unstructured":"Provias J, Claffey K, delAguila L, et al.: Meningiomas: role of vascular endothelial growth factor\/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery 1997, 40:1016\u20131026.","journal-title":"Neurosurgery"},{"key":"34_CR59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-007-0251-4","volume":"114","author":"V. Barresi","year":"2007","unstructured":"Barresi V, Cerasoli S, Vitarelli E, Tuccari G: Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 2007, 114:147\u2013156.","journal-title":"Acta Neuropathol"},{"key":"34_CR60","first-page":"817","volume":"10","author":"T. Kaley","year":"2008","unstructured":"Kaley T, Wen P, Karimi S, et al.: Phase II trial of sunitinib (SU011248) in patients with recurrent or inoperable meningioma [abstract]. Neuro Oncol 2008, 10:817.","journal-title":"Neuro Oncol"},{"key":"34_CR61","first-page":"824","volume":"10","author":"R. Deboer","year":"2008","unstructured":"Deboer R, Grimm S, Chandler J, et al.: A phase II trial of PTK787\/ZK 222584 in recurrent or progressive meningioma [abstract]. Neuro Oncol 2008, 10:824.","journal-title":"Neuro Oncol"},{"key":"34_CR62","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/ijc.21255","volume":"117","author":"L. Klaeboe","year":"2005","unstructured":"Klaeboe L, Lonn S, Scheie D, et al.: Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968\u20131997. Int J Cancer 2005, 117:996\u20131001.","journal-title":"Int J Cancer"},{"key":"34_CR63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.25.8.705","volume":"25","author":"B.S. Schoenberg","year":"1975","unstructured":"Schoenberg BS, Christine BW, Whisnant JP: Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 1975, 25:705\u2013712.","journal-title":"Neurology"},{"key":"34_CR64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2007.14.2133","volume":"26","author":"S. Blitshteyn","year":"2008","unstructured":"Blitshteyn S, Crook JE, Jaeckle KA: Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 2008, 26:279\u2013282.","journal-title":"J Clin Oncol"},{"key":"34_CR65","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cncr.22783","volume":"110","author":"E.B. Claus","year":"2007","unstructured":"Claus EB, Black PM, Bondy ML, et al.: Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 2007, 110:471\u2013476.","journal-title":"Cancer"},{"key":"34_CR66","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMc071938","volume":"357","author":"R. Gazzeri","year":"2007","unstructured":"Gazzeri R, Galarza M, Gazzeri G: Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med 2007, 357:2411\u20132412.","journal-title":"N Engl J Med"},{"key":"34_CR67","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-6-152","volume":"6","author":"B. Custer","year":"2006","unstructured":"Custer B, Longstreth WT Jr, Phillips LE, et al.: Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 2006, 6:152.","journal-title":"BMC Cancer"},{"key":"34_CR68","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1158\/1055-9965.EPI-08-0406","volume":"17","author":"A. Wigertz","year":"2008","unstructured":"Wigertz A, Lonn S, Hall P, et al.: Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev 2008, 17:2663\u20132670.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"34_CR69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01050266","volume":"15","author":"J.W. Goodwin","year":"1993","unstructured":"Goodwin JW, Crowley J, Eyre HJ, et al.: A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neurooncol 1993, 15:75\u201377.","journal-title":"J Neurooncol"},{"key":"34_CR70","first-page":"222","volume":"20","author":"S.M. Grunberg","year":"2001","unstructured":"Grunberg SM, Rankin C, Townsend J, et al.: Phase III double-blind randomized placebo-controlled study of mifepristone (RU) for the treatment of unresectable meningioma [abstract]. Proc ASCO 2001, 20:222.","journal-title":"Proc ASCO"},{"key":"34_CR71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3171\/jns.2001.94.3.0487","volume":"94","author":"I.E. McCutcheon","year":"2001","unstructured":"McCutcheon IE, Flyvbjerg A, Hill H, et al.: Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J Neurosurg 2001, 94:487\u2013492.","journal-title":"J Neurosurg"},{"key":"34_CR72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.1.01825","volume":"152","author":"W.M. Drake","year":"2005","unstructured":"Drake WM, Grossman AB, Hutson RK: Effect of treatment with pegvisomant on meningioma growth in vivo. Eur J Endocrinol 2005, 152:161\u2013162.","journal-title":"Eur J Endocrinol"},{"key":"34_CR73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:NEON.0000013498.19981.55","volume":"66","author":"S. Arena","year":"2004","unstructured":"Arena S, Barbieri F, Thellung S, et al.: Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity. J Neurooncol 2004, 66:155\u2013166.","journal-title":"J Neurooncol"},{"key":"34_CR74","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1212\/01.wnl.0000271382.62776.b7","volume":"69","author":"M.C. Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Fadul CE: Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology 2007, 69:969\u2013973.","journal-title":"Neurology"},{"key":"34_CR75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","volume":"146","author":"C. Bruns","year":"2002","unstructured":"Bruns C, Lewis I, Briner U, et al.: SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 2002, 146:707\u2013716.","journal-title":"Eur J Endocrinol"},{"key":"34_CR76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1005853720926","volume":"37","author":"T.W. Dziuk","year":"1998","unstructured":"Dziuk TW, Woo S, Butler EB, et al.: Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 1998, 37:177\u2013188.","journal-title":"J Neurooncol"},{"key":"34_CR77","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","volume":"80","author":"B.J. Goldsmith","year":"1994","unstructured":"Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80:195\u2013201.","journal-title":"J Neurosurg"},{"key":"34_CR78","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0090-3019(03)00320-3","volume":"60","author":"A.E. Harris","year":"2003","unstructured":"Harris AE, Lee JY, Omalu B, et al.: The effect of radiosurgery during management of aggressive meningiomas. Surg Neurol 2003, 60:298\u2013305; discussion 305.","journal-title":"Surg Neurol"},{"issue":"Suppl3","key":"34_CR79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3171\/jns.2000.93.supplement_3.0062","volume":"93","author":"S.G. Ojemann","year":"2000","unstructured":"Ojemann SG, Sneed PK, Larson DA, et al.: Radiosurgery for malignant meningioma: results in 22 patients. J Neurosurg 2000, 93(Suppl 3):62\u201367.","journal-title":"J Neurosurg"},{"key":"34_CR80","first-page":"1029","volume":"49","author":"S.L. Stafford","year":"2001","unstructured":"Stafford SL, Pollock BE, Foote RL, et al.: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49:1029\u20131037; discussion 1037\u20131028.","journal-title":"Neurosurgery"},{"key":"34_CR81","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/cncr.23803","volume":"113","author":"M.C. Chamberlain","year":"2008","unstructured":"Chamberlain MC, Glantz MJ: Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 2008, 113:2146\u20132151.","journal-title":"Cancer"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0034-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-009-0034-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-009-0034-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:28:16Z","timestamp":1559420896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-009-0034-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,4]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s11910-009-0034-5","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,4]]}}}